Dermatology · San Luis Obispo, CA
NPI
1518923432
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
15 Santa Rosa St
San Luis Obispo, CA, 93405
Phone (805) 541-2650
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.2M
39,755 services
Medicare patients, 2024
2,646
Average age 77
Drug cost, 2024
$1.7M
3,081 prescriptions
Company payments, 2025
$61K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael P Heffernan was code 17003 (destruction skin lesion), 19,104 times for 1,689 patients. In total Michael P Heffernan billed 39,755 services in 117 codes, and Medicare paid $2.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 19,104 | 1,689 | $5.91 | $113K |
| J3245 Injection, tildrakizumab, 1 mg | Office | 4,200 | 23 | $108.00 | $454K |
| 17000 Destruction Skin Lesion | Office | 2,940 | 1,916 | $37.87 | $111K |
| 99214 Office E&M - Established | Office | 2,637 | 1,539 | $96.53 | $255K |
| 17110 Destruction Skin Lesion | Office | 1,965 | 1,487 | $88.55 | $174K |
| 99213 Office E&M - Established | Office | 1,356 | 1,102 | $65.85 | $89K |
| 88305 Surgical Pathology Examination | Office | 1,045 | 709 | $29.74 | $31K |
| 11102 Skin Biopsy | Office | 535 | 470 | $62.60 | $33K |
| 17311 Mohs Surgery | Office | 450 | 376 | $548.96 | $247K |
| 17312 Mohs Surgery | Office | 347 | 232 | $364.84 | $127K |
| Q4159 Affinity, per square centimeter | Office | 275 | 22 | $248.33 | $68K |
| 13132 Wound Repair - All Levels | Office | 257 | 231 | $212.19 | $55K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 200 | 45 | $0.73 | $146 |
| 99204 Office E&M - New | Office | 197 | 197 | $106.85 | $21K |
| 11302 Removal or Shaving of Skin Growth | Office | 190 | 164 | $107.02 | $20K |
By year: 2022 $1.7M for 31,768 services; 2023 $2.1M for 36,128 services; 2024 $2.2M for 39,755 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 1,045 | 709 | $29.74 | $31K |
| 88304 Surgical Pathology Examination | 46 | 40 | $9.23 | $425 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael P Heffernan prescribed most often to Medicare patients was Ketoconazole, with 420 prescriptions and refills. In total Michael P Heffernan wrote 3,081 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 420 | 466 | 214 | $8,124 |
| Fluorouracil Generic | 418 | 439 | 353 | $26K |
| Triamcinolone Acetonide Generic | 276 | 293 | 175 | $2,500 |
| Hydrocortisone Generic | 186 | 186 | 154 | $895 |
| Doxycycline Hyclate Generic | 186 | 211 | 131 | $5,099 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 168 | 175 | 98 | $2,381 |
| Clobetasol Propionate Generic | 147 | 164 | 70 | $9,037 |
| Mupirocin Generic | 133 | 133 | 114 | $859 |
| Dupixent Pen Dupilumab | 115 | 120 | 17 | $446K |
| Gentamicin Sulfate Generic | 102 | 105 | 86 | $3,536 |
| Fluocinonide Generic | 89 | 90 | 59 | $2,693 |
| Ssd Silver Sulfadiazine | 80 | 84 | 74 | $447 |
| Cephalexin Generic | 65 | 67 | 52 | $403 |
| Minoxidil Generic | 62 | 149 | 24 | $655 |
| Metronidazole Generic | 53 | 58 | 41 | $2,746 |
Brand drugs: 384 claims; generic drugs: 2,697 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael P Heffernan $61K ($61K in general payments such as food, travel and fees) from 20 companies. The largest payer was Lilly USA, LLC with $36K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 28 | $36K |
| Abbvie Inc. ABBV | 10 | $20K |
| Neurocrine BioSciences, Inc. NBIX | 4 | $4,500 |
| Organogenesis Inc. ORGO | 4 | $189 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $186 |
| Janssen Biotech, Inc. JNJ | 6 | $184 |
| Galderma Laboratories, L.P. GALD.SW | 2 | $159 |
| Genzyme Corporation SNY | 1 | $150 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $144 |
| LEO Pharma Inc. | 5 | $124 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.